About University of Minnesota Health Clinical Research Unit
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at University of Minnesota Health Clinical Research Unit
During the past decade, University of Minnesota Health Clinical Research Unit conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Minnesota Health Clinical Research Unit" #1 sponsor was "Amicus Therapeutics" with 1 trials, followed by "Corbus Pharmaceuticals Inc." with 1 trials
sponsored, "ModernaTX, Inc." with 1 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Minnesota Health Clinical Research Unit"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Immune Tolerance Network (ITN)" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Rho Federal Systems Division, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at University of Minnesota Health Clinical Research Unit
According to Clinical.Site data, the most researched conditions in "University of Minnesota Health Clinical Research Unit" are
"Cytomegalovirus Infection" (1 trials), "Diffuse Cutaneous Systemic Sclerosis" (1 trials), "Eosinophilic Esophagitis" (1 trials), "Membranous Nephropathy" (1 trials) and "Nephrotic Syndrome" (1 trials). Many other conditions were trialed in "University of Minnesota Health Clinical Research Unit" in a lesser frequency.
Clinical Trials Intervention Types at University of Minnesota Health Clinical Research Unit
Most popular intervention types in "University of Minnesota Health Clinical Research Unit" are "Drug" (4 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "AT2221" (1 trials), "ATB200" (1 trials), "Belimumab" (1 trials) and "Etrasimod" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Minnesota Health Clinical Research Unit
The vast majority of trials in "University of Minnesota Health Clinical Research Unit" are
4 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at University of Minnesota Health Clinical Research Unit
Currently, there are NaN active trials in "University of Minnesota Health Clinical Research Unit".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in University of Minnesota Health Clinical Research Unit,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University of Minnesota Health Clinical Research Unit, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".